USC Scientists Develop Renewable Supply of Engineered Cancer-Fighting Immune Cells

· Science · United States

USC scientists have discovered a way to create a potentially renewable supply of genetically engineered immune cells that attack cancer and strengthen the body's natural defenses. By growing and modifying immature immune cells rather than mature ones, the researchers developed a system that can continuously produce tumor-fighting cells. The approach could address a key limitation of current cell therapies, which rely on finite batches of a patient's own mature cells. The work is at an early stage, with laboratory results reported but no clinical trials yet described.

Why it matters：If scalable, renewable engineered immune cells could broaden access to cell therapies and reduce manufacturing bottlenecks that currently limit cancer treatment.

Key points

  • The method uses immature immune cells rather than mature ones to create a continuous production system.
  • Engineered cells are designed to attack tumors and boost natural immune defenses.
  • Results are from laboratory work; clinical application is not yet reported.

Sources (original reporting)

More stories from this day